Long Non-Coding RNA H19 Prevents Lens Fibrosis through Maintaining Lens Epithelial Cell Phenotypes

The integrity of lens epithelial cells (LECs) lays the foundation for lens function and transparency. By contrast, epithelial-mesenchymal transition (EMT) of LECs leads to lens fibrosis, such as anterior subcapsular cataracts (ASC) and fibrotic forms of posterior capsule opacification (PCO). However, the underlying mechanisms remain unclear. Here, we aimed to explore the role of long non-coding RNA (lncRNA) H19 in regulating TGF-beta 2-induced EMT during lens fibrosis, revealing a novel lncRNA-based regulatory mechanism. In this work, we identified that lncRNA H19 was highly expressed in LECs, but downregulated by exposure to TGF-beta 2. In both human lens epithelial explants and SRA01/04 cells, knockdown of H19 aggravated TGF-beta 2-induced EMT, while overexpressing H19 partially reversed EMT and restored lens epithelial phenotypes. Semiin vivo whole lens culture and H19 knockout mice demonstrated the indispensable role of H19 in sustaining lens clarity through maintaining LEC features. Bioinformatic analyses further implied a potential H19-centered regulatory mechanism via Smad-dependent pathways, confirmed by in vitro experiments. In conclusion, we uncovered a novel role of H19 in inhibiting TGF-beta 2-induced EMT of the lens by suppressing Smad-dependent signaling, providing potential therapeutic targets for treating lens fibrosis.

Automated summary

This study reveals the regulatory mechanism of lncRNA H19 in lens fibrosis. The researchers found that H19 was highly expressed in lens epithelial cells but downregulated after exposure to TGF-beta 2. Silencing H19 exacerbated TGF-beta 2-induced EMT, while overexpressing H19 partially reversed EMT. In vitro and in vivo experiments confirmed the important role of H19 in maintaining lens clarity.